Wyllians Borelli

professor, clinician-scientist, neurologist. interested in cognitive reserve and glia. @borelli_lab @alzassociation @ufrgsnoticias

[Wyllians Borelli @vbwyll]

Amanhã, maiores avanços no diagnóstico, tratamento e prevenção da doença de Alzheimer e outras demências.

Gratuito, com coffee, almoço e certificados :)

Vejo vocês lá!

https://t.co/AzCiYEqvAt

[Borelli Lab @borelli_lab]

You never forget your first time 💚
The @borelli_lab team is heading for the first time to #AAIC2025, the world’s biggest event on Alzheimer’s and dementia research!
We’ve won travel awards to share our science from 🇧🇷
🗓 July 27–31 | 📍Toronto 🇨🇦
Check out our presentations!

[Agustin Ibañez @AgustinMIbanez]

In a world facing political turmoil, social exposomes, and pollution, our study reveals that these forces accelerate aging. BBAGs can help spot risks early and guide actions for healthier aging worldwide. Congrats @HernHdezL, @SandraBez9, @nanosanta & collegues: Sebastian Moguilner, Francesca Farina, @AgustinaLegaz @PavelPradoG Jhosmary Cuadros, Liset Gonzalez, @rglezgz @joaquin_migeot Carlos Coronel-Oliveros, @ETagliazucchi @MarceloMaito @godoymeugenia @josecruzat Ahmed Shaheen @DrTFarombi Daniel Salazar @DaUglione @vbwyll @erzimmer Alfred K. Njamnshi, Swati Bajpai A Dey, Cyprian Mostert, Zul Merali, @Mohamed03966736 Sara Moustafa @SolFittipaldi Florencia Altschuler, @medelero @DavidHuepe @KristineYaffe @MomohChi @HarrisAEyre @pswieboda @ProfLawlor @jjaimemiranda @durananiotz 6/6🧵

[Borelli Lab @borelli_lab]

Dr. @vbwyll in action at @congressobrain, presenting on blood biomarkers for Alzheimer’s disease 🧠🩸 — discussing when and how to implement them in clinical practice. An important step toward more accessible and earlier diagnosis.

[Wyllians Borelli @vbwyll]

Excited to announce this new step!

🧠

[Borelli Lab @borelli_lab]

👋 Hello, nice to meet you — we’re just getting started!

We are a research group led by Dr. @vbwyll, dedicated to studying Alzheimer’s and related dementias 🧠

Our mission: advance prevention, early diagnosis, and treatment through neuroscience!

[Wyllians Borelli @vbwyll]

Here we go!

@vbwyll.bsky.social

See you there :)

[Wyllians Borelli @vbwyll]

GLP-1 agonists seem to benefit individuals with abusive behavior - food intake, alcohol, drugs.

Will it work in #AD?

[JAMA Psychiatry @JAMAPsych]

GLP-1 agonists semaglutide and liraglutide may be effective in the treatment of alcohol use disorder. https://t.co/G2zYndU6wu

[Wyllians Borelli @vbwyll]

There’s no doubt that anti-amyloid will increase health discrepancy - the discussion is about the next steps.

Great discussion on Leqembi, UK, Japan and the recent European decision:

https://t.co/3EMgVD0RPL

[Wyllians Borelli @vbwyll]

@araujosalomao_ @leandrominozzo @erzimmer Conselho maior: a pesquisa muda a vida das pessoas! Como neurologista, o que me dá esperança é a pesquisa!

[Wyllians Borelli @vbwyll]

Palestra incrível do @leandrominozzo sobre a política nacional de cuidado integral a pessoas com doença de Alzheimer e outras demências. Muita coisa boa para celebrar! @erzimmer e #nitrini em foco

[Wyllians Borelli @vbwyll]

Wanna hear about blood-based biomarkers in LMIC and their clinical implementation?

Check our webinar hosted by @ISTAART PIA Real World Translation Work Group.

👇

[Breno Barbosa @brnovsk]

Today, @abneuro_ published guidelines for using #AlzheimersDisease biomarkers and anti-amyloid therapies in Brazil, a country with significant challenges. I am glad to have led this task force with colleagues and mentors. Articles available at @DementiaNeuro (links below)

[Wyllians Borelli @vbwyll]

@araujosalomao_ @leandrominozzo @erzimmer Infelizmente não :/ mas o discurso do @erzimmer sim: https://t.co/A0ve4WXlJn

[Zimmer Lab @zimmerneurolab]

Last week, the XXXI Brazilian Congress of Neurology took place, the largest event in this field in 🇧🇷! Organized by ABN, it gathered over 5k participants and featured 380+ presentations in Campinas.

Check out highlights from Dr. @erzimmer and Dr. @vbwyll!

[Wyllians Borelli @vbwyll]

It’s amazing to hear an inspiring, brilliant researcher that encourage the whole Brazilian community to keep researching.

[Eduardo Zimmer @erzimmer]

The spectacular @grinberg_t explaining why we should study sleep in brain aging and dementia at #CBN2024 😴💤🛌🥱

[Wyllians Borelli @vbwyll]

@erzimmer explaining that FDG is not THAT neurodegeneration marker.

#CBN24 at the Brazilian Congress of Neurology

[Wyllians Borelli @vbwyll]

@ArenazaEider @ReservePIA @SexAndGenderPIA @ISTAART @alzassociation Amazing work, congratulations!

[Agustin Ibañez @AgustinMIbanez]

Precision brain health can evolve by integrating computational frameworks of brain clocks + multimodal diversity, showing how inequities and exposomes impact brain health. Out in @NatureMedicine, written with editors & the great @SandraBez9 + @vbwyll 👉https://t.co/u8YZCdOtrZ

[Elisa Resende @Elisa_Resende_]

Part of the task force that published the guidelines for the use of AD biomarkers and potential use of anti-amyloid therapies in Brazil. It was an honor to work with the greatest references in this field in Brazil

[Wyllians Borelli @vbwyll]

Glad to contribute with the national consensus.

[Breno Barbosa @brnovsk]

Today, @abneuro_ published guidelines for using #AlzheimersDisease biomarkers and anti-amyloid therapies in Brazil, a country with significant challenges. I am glad to have led this task force with colleagues and mentors. Articles available at @DementiaNeuro (links below)